Entering text into the input field will update the search result below

Edwards Lifesciences' SAPIEN 3 Ultra valve CE Mark'd

Nov. 16, 2018 9:44 AM ETEdwards Lifesciences Corporation (EW) StockBy: Douglas W. House, SA News Editor
  • Edwards Lifesciences (NYSE:EW -0.2%) announces that its SAPIEN 3 Ultra transcatheter aortic valve used to treat severe symptomatic aortic stenosis is now CE Mark certified.
  • The company says the device has enhanced features compared to SAPIEN 3, including a heightened outer skirt to eliminate leaking around the valve, and an improved delivery system.
  • Commercial launch in Germany will be postponed until a patent dispute with Boston Scientific is resolved.
  • Previously: Boston Scientific prevails over Edwards Lifesciences in Sapien 3 patent dispute in Germany (Oct. 23)

Recommended For You

More Trending News

About EW Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
EW--
Edwards Lifesciences Corporation